ORIFARM A/S: Financial statements 2019
CVR: 26058708
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
ORIFARM A/S (CVR 26058708) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 1,200,155,000 and a net result of DKK 5,096,000 compared with DKK 4,295,000 the year before. That is a decrease of 4% compared with the year before. The profit margin was 0.4%. Equity in the 2019 report amounted to DKK 35,689,000. The solvency ratio was 20.4%. The company had 38 employees in the financial year.
- Revenue
- DKK 1,200,155,000
- Gross Profit
- DKK 31,438,000
- Profit/Loss
- DKK 5,096,000
- Equity
- DKK 35,689,000
- Total Assets
- DKK 175,252,000
- Employees
- 38
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 1.2 mia. | 31.4 mio. | 5.1 mio. | 35.7 mio. | 38 |
| 2018 | 1.3 mia. | 36.2 mio. | 4.3 mio. | 40.6 mio. | 45 |
| 2017 | 1.2 mia. | 34.5 mio. | 4.4 mio. | 36.3 mio. | 42 |
| 2016 | 1.2 mia. | 58 mio. | 3.6 mio. | 31.9 mio. | 72 |
| 2015 | 1 mia. | 52.2 mio. | 5.4 mio. | 28.2 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
ORIFARM A/S has published its annual report for 2018. Revenue came to DKK 1,250,457,000, and the net result was DKK 4,295,000.
As of February 1, 2019, Jens Peter Nielsen has left the board of directors of ORIFARM A/S.
As of February 1, 2019, Thomas Brandhof is registered as adm. dir. of ORIFARM A/S.
As of February 1, 2019, Tine Søndergaard Jensen has stepped down as adm. dir. of ORIFARM A/S.
About ORIFARM A/S
ORIFARM A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JUT NR. 2181 A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM PI A/S. The company has 39 employees (2026). In 2025, the company reported revenue of DKK 1,174,659,000 and a net result of DKK 9,727,000 compared with DKK 14,865,000 the year before. Equity in the 2025 report amounted to DKK 44,048,000.